Conduit Pharmaceuticals (CDTTW) Competitors $0.0097 0.00 (0.00%) As of 09:30 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock CDTTW vs. SXTPW, DRTSW, APLMW, BIVIW, and CDIOWShould you buy Conduit Pharmaceuticals stock or one of its competitors? MarketBeat compares Conduit Pharmaceuticals with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Conduit Pharmaceuticals include 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). These companies are all part of the "biotechnology" industry. CDTTW vs. SXTPWCDTTW vs. DRTSWCDTTW vs. APLMWCDTTW vs. BIVIWCDTTW vs. CDIOWHow does Conduit Pharmaceuticals compare to 60 Degrees Pharmaceuticals?Conduit Pharmaceuticals (NASDAQ:CDTTW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, media sentiment, valuation, dividends, risk and profitability. Is CDTTW or SXTPW more profitable? Company Net Margins Return on Equity Return on Assets Conduit PharmaceuticalsN/A N/A N/A 60 Degrees Pharmaceuticals N/A N/A N/A Does the media refer more to CDTTW or SXTPW? In the previous week, Conduit Pharmaceuticals' average media sentiment score of 0.00 equaled 60 Degrees Pharmaceuticals'average media sentiment score. Company Overall Sentiment Conduit Pharmaceuticals Neutral 60 Degrees Pharmaceuticals Neutral Which has preferable earnings & valuation, CDTTW or SXTPW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioConduit PharmaceuticalsN/AN/AN/AN/AN/A60 Degrees Pharmaceuticals$1.01MN/AN/AN/AN/A Summary60 Degrees Pharmaceuticals beats Conduit Pharmaceuticals on 1 of the 1 factors compared between the two stocks.How does Conduit Pharmaceuticals compare to Alpha Tau Medical?Conduit Pharmaceuticals (NASDAQ:CDTTW) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, profitability, institutional ownership, media sentiment and earnings. Is CDTTW or DRTSW more profitable? Company Net Margins Return on Equity Return on Assets Conduit PharmaceuticalsN/A N/A N/A Alpha Tau Medical N/A N/A N/A Which has preferable earnings & valuation, CDTTW or DRTSW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioConduit PharmaceuticalsN/AN/AN/AN/AN/AAlpha Tau MedicalN/AN/AN/AN/AN/A Does the media favor CDTTW or DRTSW? In the previous week, Alpha Tau Medical had 1 more articles in the media than Conduit Pharmaceuticals. MarketBeat recorded 1 mentions for Alpha Tau Medical and 0 mentions for Conduit Pharmaceuticals. Conduit Pharmaceuticals' average media sentiment score of 0.00 equaled Alpha Tau Medical'saverage media sentiment score. Company Overall Sentiment Conduit Pharmaceuticals Neutral Alpha Tau Medical Neutral SummaryAlpha Tau Medical beats Conduit Pharmaceuticals on 1 of the 1 factors compared between the two stocks.How does Conduit Pharmaceuticals compare to Apollomics?Apollomics (NASDAQ:APLMW) and Conduit Pharmaceuticals (NASDAQ:CDTTW) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, media sentiment, valuation, dividends, earnings, institutional ownership and analyst recommendations. Does the media prefer APLMW or CDTTW? In the previous week, Apollomics' average media sentiment score of 0.00 equaled Conduit Pharmaceuticals'average media sentiment score. Company Overall Sentiment Apollomics Neutral Conduit Pharmaceuticals Neutral Which has stronger valuation & earnings, APLMW or CDTTW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioApollomics$8.50MN/AN/AN/AN/AConduit PharmaceuticalsN/AN/AN/AN/AN/A Is APLMW or CDTTW more profitable? Company Net Margins Return on Equity Return on Assets ApollomicsN/A N/A N/A Conduit Pharmaceuticals N/A N/A N/A SummaryApollomics beats Conduit Pharmaceuticals on 1 of the 1 factors compared between the two stocks.How does Conduit Pharmaceuticals compare to BioVie?Conduit Pharmaceuticals (NASDAQ:CDTTW) and BioVie (NASDAQ:BIVIW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends. Is CDTTW or BIVIW more profitable? Company Net Margins Return on Equity Return on Assets Conduit PharmaceuticalsN/A N/A N/A BioVie N/A N/A N/A Which has preferable earnings & valuation, CDTTW or BIVIW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioConduit PharmaceuticalsN/AN/AN/AN/AN/ABioVieN/AN/AN/AN/AN/A Does the media prefer CDTTW or BIVIW? In the previous week, Conduit Pharmaceuticals' average media sentiment score of 0.00 equaled BioVie'saverage media sentiment score. Company Overall Sentiment Conduit Pharmaceuticals Neutral BioVie Neutral SummaryConduit Pharmaceuticals and BioVie tied by winning 0 of the 0 factors compared between the two stocks.How does Conduit Pharmaceuticals compare to Cardio Diagnostics?Cardio Diagnostics (NASDAQ:CDIOW) and Conduit Pharmaceuticals (NASDAQ:CDTTW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, media sentiment, profitability and institutional ownership. Is CDIOW or CDTTW more profitable? Company Net Margins Return on Equity Return on Assets Cardio DiagnosticsN/A N/A N/A Conduit Pharmaceuticals N/A N/A N/A Does the media favor CDIOW or CDTTW? In the previous week, Cardio Diagnostics' average media sentiment score of 0.00 equaled Conduit Pharmaceuticals'average media sentiment score. Company Overall Sentiment Cardio Diagnostics Neutral Conduit Pharmaceuticals Neutral Which has higher earnings & valuation, CDIOW or CDTTW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCardio Diagnostics$14.83KN/AN/AN/AN/AConduit PharmaceuticalsN/AN/AN/AN/AN/A SummaryCardio Diagnostics beats Conduit Pharmaceuticals on 1 of the 1 factors compared between the two stocks. Get Conduit Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CDTTW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDTTW vs. The Competition ExportMetricConduit PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$465.73M$6.25B$12.23BDividend YieldN/A3.87%2.80%5.27%P/E RatioN/A3.7620.7925.04Price / SalesN/A7,435.94531.2172.18Price / CashN/A13.1343.0954.25Price / BookN/A83.539.816.83Net IncomeN/A-$96.07M$3.55B$335.69M7 Day PerformanceN/A0.52%-2.07%-2.03%1 Month PerformanceN/A0.18%-3.90%-1.90%1 Year PerformanceN/A71.17%29.39%27.36% Conduit Pharmaceuticals Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDTTWConduit PharmaceuticalsN/A$0.01flatN/A+59.1%$0.00N/AN/A7Gap UpSXTPW60 Degrees PharmaceuticalsN/A$0.05+13.6%N/AN/A$0.00$1.01MN/A2Short Interest IncreaseGap DownDRTSWAlpha Tau MedicalN/A$1.80+2.3%N/A+891.2%$0.00N/AN/A80News CoverageUpcoming EarningsGap DownAPLMWApollomicsN/A$0.02+1.2%N/A+47.0%$0.00$8.50MN/A59Positive NewsGap DownBIVIWBioVieN/A$0.35+22.4%N/AN/A$0.00N/AN/AN/APositive NewsGap Up Related Companies and Tools Related Companies SXTPW Alternatives DRTSW Alternatives APLMW Alternatives BIVIW Alternatives CDIOW Alternatives CELUW Alternatives CEROW Alternatives CINGW Alternatives CMRAW Alternatives DRMAW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CDTTW) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Conduit Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Conduit Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
